On March 3, 2021 Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology and neuroscience reported that Kineta will be presenting at multiple virtual investor events in March 2021 (Press release, Kineta, MAR 3, 2021, https://kinetabio.com/2021/03/03/kineta-presents-at-conferences-march-2021/?utm_source=rss&utm_medium=rss&utm_campaign=kineta-presents-at-conferences-march-2021 [SID1234576000]). Shawn Iadonato, Kineta Chief Executive Officer and Craig Philips, President, will present an overview of the company with a focus on its novel VISTA immuno-oncology program at the following events:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 41st Annual Health Care Conference
March 1-4, 2021
Private company presentations

H.C. Wainwright Global Life Sciences Conference
March 9-10, 2021
Private company presentations

Solebury Trout Virtual Spring Private Company Showcase
March 11, 2021 11:20-11:40AM Pacific

Life Science Innovation Northwest
March 30-31, 2021